Atlas Trials

Qiming Wang

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Qiming Wang

RecordFirmDate
Efficacy and Safety of Ensartinib Combined With Anlotinib in Lorlatinib-Resistant ALK-Positive NSCLC (NCT07671560)Qiming Wang2026-07-01
High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis (NCT06971406)Qiming Wang2025-05-15
A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases (NCT06926803)Qiming Wang2025-03-01

Track Qiming Wang automatically

Every clearance here is in the API, with alerts when new ones post.